News Releases Year None2024202320222021 February 16, 2024 /C O R R E C T I O N -- YS Biopharma Co., Ltd./ February 16, 2024 YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting February 14, 2024 YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance February 14, 2024 YS Biopharma Announces Appointment of New Directors February 12, 2024 YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd. February 9, 2024 YS Biopharma Announces US$40 Million Private Placement Financing January 22, 2024 YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024 January 8, 2024 YS Biopharma Announces Changes to its Board Committees Print Page Email Alerts RSS Feeds Contact IR
Year None2024202320222021 February 16, 2024 /C O R R E C T I O N -- YS Biopharma Co., Ltd./ February 16, 2024 YS Biopharma Announces Results of Extraordinary General Meeting and Responds to False Statements about the Meeting February 14, 2024 YS Biopharma to Hold an Extraordinary General Meeting on February 22, 2024 pursuant to a Shareholder Requisition to Enhance Corporate Governance February 14, 2024 YS Biopharma Announces Appointment of New Directors February 12, 2024 YS Biopharma Responds to a Notice of Extraordinary General Meeting of Shareholders of YS Biopharma Co., Ltd. February 9, 2024 YS Biopharma Announces US$40 Million Private Placement Financing January 22, 2024 YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024 January 8, 2024 YS Biopharma Announces Changes to its Board Committees